Other
Lip
0
Pipeline Programs↗
11
Active Trials↗
24
Companies Involved↗
Lip is an early-stage landscape with 0 programs across 24 companies. The most active players are Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Merck & Co., Novartis.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
160
clinical trials
Completed119 · 74%
Unknown status13 · 8%
Terminated11 · 7%
Recruiting7 · 4%
Withdrawn6 · 4%
Not yet recruiting2 · 1%
Other2 · 1%
Clinical Trials
Trial Activity
160 trials
Lipid Transport Disorder Italian Genetic Record (LIPIGEN)
Recruiting·FFondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)·N/A·NCT06362473·10,000 enrolled
Lipoic Acid Supplement for Cystine Stone
Active, not recruiting·—·Phase 2·NCT02910531·50 enrolled
Page 1 of 11
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)